MENU
+Compare
POAI
Stock ticker: NASDAQ
AS OF
Nov 19, 01:33 PM (EDT)
Price
$6.18
Change
+$0.15 (+2.49%)
Capitalization
20.76M

POAI stock forecast, quote, news & analysis

Predictive Oncology Inc functions in the healthcare domain... Show more

POAI
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for POAI with price predictions
Nov 18, 2025

POAI in downward trend: price dove below 50-day moving average on October 15, 2025

POAI moved below its 50-day moving average on October 15, 2025 date and that indicates a change from an upward trend to a downward trend. In of 40 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day moving average for POAI crossed bearishly below the 50-day moving average on October 17, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where POAI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for POAI entered a downward trend on November 18, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where POAI's RSI Indicator exited the oversold zone, of 39 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 60 cases where POAI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for POAI just turned positive on November 14, 2025. Looking at past instances where POAI's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where POAI advanced for three days, in of 224 cases, the price rose further within the following month. The odds of a continued upward trend are .

POAI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.097) is normal, around the industry mean (21.335). P/E Ratio (0.000) is within average values for comparable stocks, (105.249). POAI's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.395). Dividend Yield (0.000) settles around the average of (0.028) among similar stocks. P/S Ratio (1.743) is also within normal values, averaging (67.320).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. POAI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. POAI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Teladoc Health (NYSE:TDOC).

Industry description

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

Market Cap

The average market capitalization across the Services to the Health Industry Industry is 2.16B. The market cap for tickers in the group ranges from 9 to 44.86B. VEEV holds the highest valuation in this group at 44.86B. The lowest valued company is MDPEF at 9.

High and low price notable news

The average weekly price growth across all stocks in the Services to the Health Industry Industry was -6%. For the same Industry, the average monthly price growth was -12%, and the average quarterly price growth was 7%. VASO experienced the highest price growth at 25%, while EVAHF experienced the biggest fall at -41%.

Volume

The average weekly volume growth across all stocks in the Services to the Health Industry Industry was -82%. For the same stocks of the Industry, the average monthly volume growth was 17% and the average quarterly volume growth was 135%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 56
P/E Growth Rating: 70
Price Growth Rating: 62
SMR Rating: 83
Profit Risk Rating: 95
Seasonality Score: 13 (-100 ... +100)
View a ticker or compare two or three
POAI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a company, which engages in the manufacture and distribution of healthcare products, and provision of related services.

Industry ServicestotheHealthIndustry

Profile
Fundamentals
Details
Industry
N/A
Address
No.91 43rd Street
Phone
+1 412 432-1500
Employees
35
Web
https://www.predictive-oncology.com